medical waste treatment
Scope
Date
~
-
Bio & Pharma
Medical IP's X-ray image analysis software certified as medical device
Medical IP, a South Korean medical AI company, has announced that its artificial intelligence (AI) medical image analysis software "TiSepX Lung Volu...
Mar 08, 2023 (Gmt+09:00)
-
Waste management
SK Incheon Petrochemical invests in domestic recycling waste tire startup
SK Incheon Petrochemical, a subsidiary of South Korea’s SK Innovation Co., on Sunday said it made an equity investment in the eco-friendly sta...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada
Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...
Mar 06, 2023 (Gmt+09:00)
-
Healthcare
Kakao Healthcare to launch diabetes monitoring app
South Korea’s dominant mobile platform Kakao Corp. will kick off its healthcare services this year with the launch of a diabetes monitoring ap...
Mar 03, 2023 (Gmt+09:00)
-
Waste management
SK Ecoplant launches 4th plant in US
South Korea's environment-focused energy company SK Ecoplant Co. on Thursday said it added a base for recycling electrical and electronic waste and ...
Mar 02, 2023 (Gmt+09:00)
-
Chemical Industry
Kolon Plastics to make eco-friendly products from marine waste
Kolon Plastics Inc. said on Tuesday that it has signed an agreement with Netspa, a South Korean recycling social venture, to jointly develop enginee...
Feb 28, 2023 (Gmt+09:00)
-
Waste management
SK Ecoplant to establish virtuous cycle ecosystem for waste resources
SK Ecoplant Co., a subsidiary of South Korea's SK Group that focuses on recycling, construction and renewable energy, announced on Tuesday a busines...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s stent maker Taewoong Medical acquired by Olympus for $370 million
Japanese medical device company Olympus on Saturday said it will wholly acquire South Korea’s Taewoong Medical, a maker of gastrointestinal (G...
Feb 27, 2023 (Gmt+09:00)
-
ESG
S.Korea's HMM establishes system for recycling waste ropes
South Korea's HMM Co. announced on Tuesday that it had signed a business agreement with Foresys, a company specializing in marine waste management. ...
Feb 21, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
LG Uplus, Ecorbit to build smart safety solution at waste disposal site
LG Uplus Corp., a South Korean mobile telecom service carrier, announced on Monday that it is deploying a smart safety solution at waste disposal co...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Hwajin Medical gets FDA sales approval for syringes
HLB Therapeutics Co. announced Thursday that Sofjec, a syringe produced by its subsidiary Hwajin Medical, has been approved for sale by the US Food ...
Feb 17, 2023 (Gmt+09:00)
-
Artificial intelligence
AI medical software company Lunit to open subsidiary in Europe
South Korea's Lunit, an artificial intelligence (AI) medical software company, on Friday said its board meeting held on the previous day decided to ...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
AIMMED’s Somzz ushers in digital therapeutic device market in Korea
South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...
Feb 16, 2023 (Gmt+09:00)
-
Energy
SK Ecoplant enters bioenergy sector with waste-to-fuel tech
South Korea's SK Ecoplant Co. will supply fuel made from the conversion of food waste.The company on Thursday said it entered the bioenergy market a...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm holds sales meeting for marketing Cenobamate in US
On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Plasma, Janssen Korea sign sales, distribution agreement
SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanall Biopharma invests in Interon Labs for brain disease treatments
South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Coreline Soft to supply AI diagnosis solution to France
Coreline Soft, a South Korean company specializing in developing medical artificial intelligence (AI) devices, said on Tuesday that it has signed an...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Venture capital
Korea's venture capital investment falls 12% last year amid downturn
South Korea's venture capital investment last year fell more than 10% from a year ago due to the economic downturn caused by a series of global rate...
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N to introduce biosimilars for bone disease treatment from Spain
South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Korean startups
S.Korea's waste recycler ReCo lands $11.8 million in investment
South Korea's startup ReCo, which runs the comprehensive waste collection and transportation service UpBox, on Wednesday said it attracted Series B ...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)